Rising number of people suffering from endometriosis, increasing demand for novel drugs and hormonal therapies, and ongoing R&D activities for advanced endometriosis treatments are among the key factors expected to drive market revenue growth.
Rising number of people suffering from endometriosis, increasing demand for novel drugs and hormonal therapies, and ongoing R&D activities for advanced endometriosis treatments are among the key factors expected to drive market revenue growth
New York, December 17, 2021 – Reports and Data has published its latest report titled “Endometriosis Market, By Diagnostic Method (Ultrasound, Pelvic Examination, Laparoscopy, Magnetic Resonance Imaging, Hysteroscopy, Sonohysterography), By Drug Type (NSAIDs, Gonadotropins Releasing Hormone Agonists, Progestin, Oral Contraceptive Pills), By Treatment (Hormonal Therapy, Pain Management) By End-use (Hospitals, Pharmacies, Drugstores, E-commerce), and By Region, Forecast to 2028”
According to the latest report by Reports and Data, the global endometriosis market size was USD 2060.1 Million in 2020 and is expected to reach USD 2544.2 Million in 2028 and register a revenue CAGR of 2.6% during the forecast period, 2021-2028.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/2553
Drivers, Restraints, and Opportunities:
Factors contributing to the global endometriosis market revenue growth include rising prevalence of endometriosis and other gynecological disorders, emergence of novel drugs and treatment options for the disease, increasing concerns about women’s health – most importantly, reproductive health, and increasing research & development activities for development of more advanced effective drugs and therapies for the disorder. Market revenue growth is also driven by factors such as increasing government initiatives to raise women’s health awareness – often via social media, educational programs, and ad campaigns – growing focus on early disease diagnosis and treatment, development of advanced hormone therapeutics for endometriosis treatment, and rapidly advancing global healthcare infrastructure. Furthermore, the global endometriosis market revenue growth is driven by rising demand for non-invasive or minimally invasive surgical procedures and increasing availability of advanced diagnostic methods.
Endometriosis is a progressive inflammatory condition characterized by growth of tissues lining the uterus outside the uterine cavity. It is one of the most prevalent chronic gynecological disorders in the world and affects over 11% of the female population, between ages 15 and 44 years. The condition results in scar tissue formations called endometrial implants within the pelvic region that cause acute irritation, excessive bleeding during menstruation, and formation of cysts in the ovary. Endometriosis can lead to blockage in the fallopian tubes and cause serious problems related to the intestines and bladders. It can disrupt various reproductive functions, leading to depression, fatigue, nausea, and impaired sexual functions. Common symptoms of the condition are severe menstrual pain, excessive bleeding, acute pain during sexual intercourse, painful urination and bowel movements, and chronic pelvic pain.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
To know more about the report @ https://www.reportsanddata.com/report-detail/endometriosis-market
Laparoscopy Segment to Lead in Terms of Fastest Revenue CAGR:
Based on diagnostic method, the global endometriosis market is segmented into ultrasound, pelvic exam, laparoscopy, MRI, hysteroscopy, and sonohysterography. The laparoscopy segment is expected to register the fastest revenue growth rate over the forecast period. Increasing prevalence of gynecological disorders such as endometriosis, rising preference for non-invasive or minimally invasive surgical procedures, growing use of advanced laparoscopic instruments, and increasing awareness of laparoscopic surgeries are major factors expected to drive revenue growth of this segment.
Drugstores Segment Accounted for Significant Revenue Growth in 2020:
Based on end-use, the global endometriosis market is segmented into hospitals, pharmacies, drugstores, and e-commerce. The drugstores segment accounted for largest revenue share in the global market in 2020 owing to factors such as growing prevalence of endometriosis across the globe and increasing availability of numerous prescription and over-the-counter medications for primary treatment of the condition.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America endometriosis market dominated other regional markets in terms of revenue share in the global market in 2020. Rising prevalence of chronic gynecological disorders (including endometriosis), growing awareness of female reproductive health, increasing availability of advanced women’s healthcare services, and technological advances in surgical procedures and equipment are major contributors to the North America market revenue growth. Increasing regulatory approvals of novel drugs and therapeutics and presence of state-of-the-art healthcare infrastructure in the region are some other factors expected to further boost the regional market revenue growth.
Major Companies in the Global Endometriosis Market Include:
- AbbVie Inc.
- AstraZeneca Plc.
- Bayer HealthCare Pharmaceuticals
- Debiopharm International SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Meditrina Pharmaceuticals Inc.
- Pfizer, Inc.
- Eli Lilly and Company
- Abbott Laboratories
- Neurocrine Biosciences, Inc.
- Astellas Pharma Inc.
- Evotec AG
- Addex Therapeutics
- Kissei Pharmaceutical Co., Ltd.
- ElexoPharm
- EndoCeutics
- Gedeon Richter Plc
- Myovant Sciences
- Mayne Pharma Group Ltd
- Merck & Co.
Buy Premium Research Report @ https://www.reportsanddata.com/checkout-form/2553
Market Segmentation:
For the purpose of this report, Reports and Data has segmented the global endometriosis market based on diagnostic method, drug type, treatment, end use, and region:
Diagnostic Method Outlook (Revenue, USD Million; 2018-2028)
- Ultrasound
- Laparoscopy
- Magnetic Resonance Imaging (MRI)
- Pelvic Examination
- Hysteroscopy
- Sonohysterography
Drug Type Outlook (Revenue, USD Million; 2018-2028)
- NSAIDs
- Gonadotropins Releasing Hormone Agonists
- Progestin
- Oral Contraceptive Pills
Treatment Outlook (Revenue, USD Million; 2018-2028)
- Hormonal Therapy
- Pain Management
End-use Outlook (Revenue, USD Million; 2018-2028)
- Hospitals
- Pharmacies
- Drugstores
- E-commerce
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/2553
Regional Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Israel
- Rest of Middle East & Africa
Explore Latest Trending Research Reports By Reports and Data’s
Healthcare Equipment Leasing Market Size, Share, And Industry Analysis By Type (Surgical and Therapy Leasing Equipment, Digital and Electronic Equipment, Storage and Transport Leasing Equipment, Personal and Homecare Leasing Equipment, and DME), By Application (Hospitals, Diagnostic Centers, and Others), and By Region Forecast To 2028
Cell and Tissue Preservation Market By Type (Media, Equipment, Accessories, Alarms, Monitoring Systems, and Incubators); By Application (Therapeutics, Research & Development, Drug Discovery, Cell Therapy, Gene Therapy, and IVF Treatments); and By Region Forecast To 2028
Hospice Market Size, Share, And Industry Analysis By Type (Acute Care and Respite Care), By Application (Home Settings, Hospitals, Hospice Care Centers, and Specialty Nursing Homes), and By Region Forecast To 2028
Hair Supplements Market By Form (Capsules, Tablets, Pills, Power Gummies, Others), By Ingredient Type (Vitamin A, Vitamin C, Vitamin D, Vitamin E, Biotin, Niacin, Folic Acid, Omega 3 Fatty Acids, Saw Palmetto Extract, Minerals, Others), By Distribution Channel (Supermarkets & Hypermarkets, Retail Pharmacies, Online Channels, Others), and By Region, Forecast to 2028
Mobile ECG Monitor Market Size, Share And Industry Analysis By Type (Wearables, Tablets and Smartphone, Portable ECG Receivers, and Others), By Application (Home and Personal, Hospitals and Clinics, and Ambulatory Surgical Centers), and By Region Forecast To 2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-endometriosis-market